Bio Invention Catches Cancers That Often Fly Under the Radar!

Written by Anil Bajnath, MD
Posted November 8, 2021

Dear Longevity Insider,

Anil Bajnath MD here with your Monday roundup.

As some people age, they get hesitant about going to the doctor’s. Some are overtaken by a fear of the unknown. “What if I’m sick? What if I have cancer? I’d rather not know at all.”

Many would prefer to live their life in a bubble until it’s too late. You’ve heard the term, “Ignorance is bliss.”

Science says otherwise, especially when it comes to cancer.

Could you imagine finding out that you have stage 3 cancer that could have been identified (and treated) a year prior?

Imagine the pain and agony that would inflict on all of your loved ones. Imagine all of the years you could be missing out on with family vacations, spending time with your grandchildren and great grandchildren.

You have too much at stake to be lackadaisical with your health, with your longevity. Cancer is expected to soon be the leading cause of death in the U.S. in 2021. So here’s a fascinating test you can’t afford to be oblivious about.

Meet Galleri™. It’s a multi-cancer early cancer detection test. It can detect more than 50 types of cancers through an easy blood draw.

Minetta Liu, MD, an oncologist at Mayo Clinic, played a huge role in the development of Galleri. She too is excited about this ground-breaking invention:

Today, many cancers are found too late, leading to poor outcomes. The ability to detect cancer early is critical to successful treatment.

Even more to consider, the recommended cancer screening tests only cover five cancer types, while screening for one type of cancer at a time.

The problem is that 71% of cancer deaths are caused by the other remaining cancers that people are diagnosed with.

So there’s much need for the Galleri.

Performing as Promised

Scientists used the test in the Circulating Cell-Free Genome Atlas (CCGA) Study. And the test performed just as promised:

  1. More than 50 types of cancer were detected.
  2. Low false-positive rate of less than 1%.
  3. Pinpoints where in the body the cancer is located.

Dr. Josh Ofman, Chief Medical Officer and Head of External Affairs at GRAIL, offers his gratitude:

We are grateful to Mayo Clinic for its dedication to advancing new technologies for early cancer detection and for playing a pivotal role in the development of Galleri. 

A simple blood test capable of detecting more than 50 cancers is a ground-breaking advancement and could have a tremendous human and economic benefit.

This is truly a day of celebration in the world of science, health, and longevity. The sooner we catch signs of complications, the better!

Researchers have also linked many age-related diseases to a naturally occurring process in your body. And here's a science-backed method for approaching this dilemma...

To your longevity,

Anil Bajnath MD
CEO/Founder, Institute for Human Optimization
Chief Medical Officer, Longevity Insider HQ